Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Gregory B Lesinski"'
Autor:
Cameron Herting, Yuchen Zhang, Kavita M. Dhodapkar, Shishir K. Maithel, Mohammad Y. Zaidi, Christina Wu, Mehmet Akce, Amanda Ruggieri, Bassel F. El-Rayes, Madhav V. Dhodapkar, Gregory B. Lesinski, Olatunji B. Alese, Juan M. Sarmiento, Michael B. Ware, Deon B. Doxie, Rafi Ahmed
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundPancreatic ductal adenocarcinoma (PDAC) has yet to widely benefit from T cell-targeted immunotherapy and displays universally poor prognosis. Thus, enhancing the activity of immunotherapy is a high priority. Our laboratory recently reported
Publikováno v:
Journal for Immunotherapy of Cancer
Pancreatic ductal adenocarcinoma (PDAC) is plagued by a dismal 5-year survival rate, early onset of metastasis and limited efficacy of systemic therapies. This scenario highlights the need to fervently pursue novel therapeutic strategies to treat thi
Autor:
Timothy D. Eubank, Michael C. Ostrowski, Wendy L. Frankel, Thomas A. Mace, Reena Shakya, Thomas Ludwig, Mark Bloomston, Mitch A. Phelps, Gregory B. Lesinski, Tanios Bekaii-Saab, Jason Pitaressi
Publikováno v:
Journal for Immunotherapy of Cancer
Meeting abstracts Pancreatic ductal adenocarcinoma (PDA) has a prominent stroma which includes collagen, lymphoid, myeloid, and stellate cells. Adequate preclinical models are needed to advance immunotherapy for PDA. Indeed many xenograft models poor